Skip to main content

Market Overview

12 Biotechs With Binary Events Coming This Year

12 Biotechs With Binary Events Coming This Year

RBC Capital analyst Adnan Butt recently named 12 biotech stocks with major binary events expected in 2016.

Here’s a breakdown of the full list.

  • Aerie Pharmaceuticals Inc (NASDAQ: AERI): Phase 3 data for Rhopressa and Roclatan
  • Aptose Biosciences Inc (NASDAQ: APTO): Phase 1 data for APTO-253
  • ArQule, Inc. (NASDAQ: ARQL): Phase 3 interim for tivantinib and Phase 1 data/update for ARQ-092 in Proteus syndrome
  • Curis, Inc. (NASDAQ: CRIS): Phase 1 update from CUDC-907, CA-170 and potential additional programs
  • Endocyte, Inc. (NASDAQ: ECTY): Phase 1 data for EC1456 and EC1169
  • Intra-Cellular Therapies Inc (NASDAQ: ITCI): Phase 3 data for ITI-007
  • The Medicines Company (NASDAQ: MDCO): Phase 2 data for MDCO-216 and ALN-PCSsc and Phase 3 data for Caravance
  • Oculus Innovative Sciences, Inc. (NASDAQ: OCLS): Phase 3 data for OTX-DP, regulatory clarity on OTX-TP development and a POC study or partnership for anti-VEGF IHD
  • SCYNEXIS Inc (NASDAQ: SCYX): Phase 1 and Phase 2 data for i.v. and oral SCY-078
  • Steadymed Ltd (NASDAQ: STDY): Acceptance of Trevyent for review
  • Synthetic Biologics Inc (NYSE: SYN): Phase 2 data from SYN-010 and possibly SYN-004
  • XOMA Corp (ASDAQ: XOMA): Phase2/proof-of-concept data from XOMA 358 and potentially Phase 3 from gevokizuamb

Related Link: 2 Fast-Growing Marketing Startups You've Never Heard Of

Butt sees “significant upside” for most of these companies in the case of a positive result, but adds that the sell-off following negative results would most likely be temporary in the majority of cases.

Disclosure: the author holds no position in the stocks mentioned.

Latest Ratings for AERI

Nov 2020HC Wainwright & Co.MaintainsBuy
Oct 2020B of A SecuritiesDowngradesNeutralUnderperform
Sep 2020GuggenheimInitiates Coverage OnBuy

View More Analyst Ratings for AERI
View the Latest Analyst Ratings


Related Articles (AERI + APTO)

View Comments and Join the Discussion!

Posted-In: Analyst Color Biotech News Previews FDA Analyst Ratings Trading Ideas General Best of Benzinga

Latest Ratings

GDWolfe ResearchDowngrades
QRTEAB of A SecuritiesInitiates Coverage On
ABB of A SecuritiesDowngrades42.0
VCTRB of A SecuritiesUpgrades32.0
BSIGB of A SecuritiesUpgrades27.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at